Terragen Holdings Ltd (AU:TGH)
ASX:TGH
Top Page
Terragen Holdings Ltd
(Sydney:TGH)
Select Model
Select Model
Rating:42Neutral
Price Target:
AU$0.02
â–¼(-5.00% Downside)
Action:UpgradedDate:03/04/26
The score is primarily constrained by weak financial performance (declining revenue, ongoing losses, and negative operating/free cash flow). Technicals are only mildly stabilizing with neutral RSI but negative MACD, and valuation remains challenged due to a negative P/E and no dividend support.
Positive Factors
Low Leverage
A debt-to-equity ratio of 0.11 gives Terragen durable financial flexibility. Low leverage reduces interest burden and refinancing risk, allowing the company to fund operations or opportunistic investments during industry cycles without exacerbating stress from operating losses.
Negative Factors
Revenue Decline
Declining revenue undermines scale economics and shows weakening demand or competitive pressure in the agricultural inputs market. Persisting top-line contraction reduces leverage on fixed costs, constrains margin recovery, and limits the company's ability to rebuild profitability without structural change.
Read all positive and negative factors
Positive Factors
Negative Factors
Low Leverage
A debt-to-equity ratio of 0.11 gives Terragen durable financial flexibility. Low leverage reduces interest burden and refinancing risk, allowing the company to fund operations or opportunistic investments during industry cycles without exacerbating stress from operating losses.
Read all positive factors
Terragen Holdings Ltd (TGH) vs. iShares MSCI Australia ETF (EWA)
Market Cap
AU$16.46M
Dividend YieldN/A
Average Volume (3M)27.47K
Price to Earnings (P/E)―
Beta (1Y)-1.01
Revenue Growth-24.42%
EPS Growth-2.30%
CountryAU
EmployeesN/A
SectorBasic Materials
Sector Strength58
IndustryAgricultural Inputs
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding823,199,000
10 Day Avg. Volume51,927
30 Day Avg. Volume27,470
Financial Highlights & Ratios
PEG Ratio0.97
Price to Book (P/B)1.27
Price to Sales (P/S)5.15
P/FCF Ratio-2.74
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Terragen Holdings Ltd Business Overview & Revenue Model
Company Description
Terragen Holdings Limited engages in the research, development, production, and sale of biological products for agriculture sector in Australia and New Zealand. It offers Mylo, an animal feed supplement; and Great Land, a liquid biological soil co...
How the Company Makes Money
null...
Terragen Holdings Ltd Financial Statement Overview
Summary
Income Statement
30
Negative
Balance Sheet
45
Neutral
Cash Flow
35
Negative
| Breakdown | TTM | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.38M | 1.62M | 2.14M | 3.28M | 2.89M | 3.65M |
| Gross Profit | 583.15K | 792.23K | 2.06M | 3.21M | 2.62M | 3.19M |
| EBITDA | -3.82M | -4.68M | -3.50M | -3.46M | -5.67M | -6.13M |
| Net Income | -3.20M | -3.72M | -3.01M | -3.23M | -5.41M | -6.10M |
Balance Sheet | ||||||
| Total Assets | 5.84M | 8.12M | 6.95M | 6.35M | 9.22M | 14.72M |
| Cash, Cash Equivalents and Short-Term Investments | 2.82M | 4.81M | 4.54M | 4.17M | 6.67M | 11.64M |
| Total Debt | 483.87K | 735.45K | 542.23K | 239.37K | 332.26K | 357.96K |
| Total Liabilities | 1.07M | 1.55M | 1.63M | 1.27M | 1.46M | 1.70M |
| Stockholders Equity | 4.78M | 6.57M | 5.32M | 5.08M | 7.76M | 13.02M |
Cash Flow | ||||||
| Free Cash Flow | -3.59M | -3.03M | -2.35M | -2.91M | -4.97M | -4.93M |
| Operating Cash Flow | -3.55M | -3.03M | -2.32M | -2.81M | -4.80M | -4.52M |
| Investing Cash Flow | -661.04K | -682.43K | -132.93K | -35.20K | -118.20K | -408.02K |
| Financing Cash Flow | 932.53K | 3.87M | 2.82M | 351.00K | -52.70K | 194.92K |
Terragen Holdings Ltd Technical Analysis
Negative
0.02
Price Trends
0.02
Negative
0.02
Negative
0.02
Negative
Market Momentum
>-0.01
Negative
46.15
Neutral
<0.01
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:TGH, the sentiment is Negative. The current price of 0.02 is below the 20-day moving average (MA) of 0.02, below the 50-day MA of 0.02, and below the 200-day MA of 0.02, indicating a bearish trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 46.15 is Neutral, neither overbought nor oversold. The STOCH value of <0.01 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AU:TGH.
Terragen Holdings Ltd Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
52 Neutral | AU$24.70M | -3.04 | -27.19% | ― | -100.00% | -182.93% | |
45 Neutral | AU$35.49M | -1.75 | -102.56% | ― | 140.94% | 88.59% | |
44 Neutral | AU$9.20M | -0.86 | -330.25% | ― | ― | 43.46% | |
43 Neutral | AU$7.28M | -1.15 | -373.61% | ― | ― | 19.94% | |
42 Neutral | AU$16.46M | -1.63 | -56.43% | ― | -24.42% | -2.30% |
* Basic Materials Sector Average
AU:TGH
Terragen Holdings Ltd
0.02
>-0.01
-20.00%
AU:CP8
Fertoz
0.07
0.04
148.15%
AU:ABX
ABx Group Limited
0.07
0.03
69.23%
AU:OLY
CropLogic Ltd.
0.06
<0.01
7.14%
AU:CDT
Castle Minerals Limited
0.04
-0.02
-30.00%
AU:RLF
RLF AgTech Ltd
0.07
0.02
53.49%
Terragen Holdings Ltd Corporate Events
Terragen Holder Falls Below 5% After Equity Raising
Apr 8, 2026
Terragen Holdings Limited has disclosed that One Funds Management Limited, acting as trustee for the Saville Capital Emerging Companies Fund, has ceased to be a substantial shareholder. The change stems from dilution of One Funds Management’...
Terragen Director Scobie Ward Significantly Increases Indirect Shareholding
Mar 30, 2026
Terragen Holdings has disclosed a significant change in the shareholding of director Scobie Dickinson Ward, whose indirect interest is held through Citicorp Nominees Pty Ltd as nominee. Following a transaction dated 30 March 2026, Ward acquired 10...
Terragen clears new share placement with cleansing notice
Mar 30, 2026
Terragen Holdings Limited has completed the issue of 191,927,526 fully paid ordinary shares at $0.022 each under an institutional placement, executed without a prospectus under the Corporations Act disclosure exemptions. The company confirmed it i...
Terragen seeks ASX quotation for 191.9 million new shares
Mar 30, 2026
Terragen Holdings Ltd has applied to the Australian Securities Exchange for quotation of 191,927,526 new fully paid ordinary shares under its ticker TGH. The move formalises the listing of securities previously flagged to the market, expanding the...
Terragen Investors Back Share Placements at General Meeting
Mar 25, 2026
Shareholders of Terragen Holdings Limited have overwhelmingly approved all resolutions put to a general meeting held on 25 March 2026, endorsing prior and future share placements. The ratification of Tranche 1 placements and approval for Tranche 2...
Terragen trial shows biostimulant lifts maize silage yields and margins
Mar 2, 2026
Terragen Holdings has released an independent commercial-scale assessment showing its Great Land Plus biostimulant increased maize silage yields by up to 12 percent over standard grower practice. The trial, conducted by on-farm trial specialist La...
Terragen Sets March 2026 Virtual General Meeting and Shifts to Digital Meeting Materials
Feb 19, 2026
Terragen Holdings Limited has called a virtual general meeting for shareholders to be held on 25 March 2026 at 10:00am Melbourne time, with access provided via an online meeting link and associated digital materials. The company is moving to prima...
Terragen Plans Major Share Placement of Nearly 192 Million Shares
Feb 5, 2026
Terragen Holdings Limited has lodged a notice with the ASX for a proposed placement of up to 191,927,526 new fully paid ordinary shares, to be issued on 30 March 2026, under its existing listing framework. The sizeable equity issuance, once comple...
Terragen Plans Major Equity Placement of Over 126 Million Shares
Feb 5, 2026
Terragen Holdings Ltd has announced a proposed placement of up to 126,254,293 new fully paid ordinary shares, to be issued on 16 February 2026, subject to ASX processes. The capital raising signals a significant equity issuance that could alter th...
Terragen Shares Halted Ahead of Material Institutional Placement
Feb 3, 2026
Terragen Holdings Limited has requested and been granted a trading halt on its shares on the ASX as it prepares to announce a material institutional placement, signalling an imminent capital raise. The halt will remain in place until either the st...
Terragen Accelerates Ruminant Probiotic Rollout Amid Global Expansion Push
Jan 30, 2026
Terragen reported strong momentum in its Terragen Probiotic for Ruminants (TPR) business, highlighted by a large-scale assessment with Mort Co at Australia’s largest single-site beef feedlot covering more than 10,000 head, alongside an 87% ...
Terragen Options Lapse, Easing Potential Share Dilution
Jan 14, 2026
Terragen Holdings Ltd, listed on the ASX under code TGH, has reported a change in its issued capital structure. The company has confirmed that 5 million options, previously on issue and exercisable at A$1.00 with an expiry date of 4 December 2025,...
Terragen Holdings Options Lapse, Trimming Potential Future Dilution
Jan 14, 2026
Terragen Holdings Limited has announced the expiry of 2,000,000 unexercised options (ASX code TGHAU) that were due to expire on 4 December 2025 with an exercise price of A$0.50. The lapse of these options slightly reduces the company’s poten...
Terragen Options Lapse as 1 Million Unexercised Securities Expire
Jan 14, 2026
Terragen Holdings Limited has confirmed the expiry of a tranche of unexercised options listed on the ASX. The company reported that 1,000,000 options, exercisable at A$0.25 and due to expire on 4 December 2025 under the code TGHAT, have lapsed wit...
Terragen Options Lapse as 1 Million Unexercised Securities Expire
Jan 14, 2026
Terragen Holdings Limited has confirmed the expiry of a tranche of unexercised options listed on the ASX. The company reported that 1,000,000 options, exercisable at A$0.25 and due to expire on 4 December 2025 under the code TGHAT, have lapsed wit...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.